Influenza type B is one of the two main types of flu virus that cause seasonal outbreaks in humans. Unlike influenza A, which infects many animal species and can trigger pandemics, type B circulates almost exclusively among people. It produces the same familiar flu symptoms as type A but tends to cause milder illness in most adults, while posing a particular risk to young children.
How Type B Differs From Type A
The flu viruses you hear about each winter belong to one of two types: A or B. Influenza A is the more common cause of seasonal flu and the only type capable of causing pandemics, because it mutates rapidly and can jump between animals and humans. Influenza B lacks that animal reservoir. It spreads person to person and changes more slowly, which makes it somewhat more predictable from year to year.
Both types cause the same core symptoms: fever (typically 100 to 102°F), body aches, headache, sore throat, cough, fatigue, and chills. Type B generally produces milder illness in healthy adults, but that distinction fades at the extremes of age. Children under 5 and older adults can develop severe cases from either type.
The Two Lineages of Influenza B
Influenza B split into two distinct genetic lineages decades ago: Victoria and Yamagata. These lineages behave differently in several ways. Victoria tends to infect very young children and mutates more quickly, making it harder to match in seasonal vaccines. Yamagata historically showed a broader age distribution, infecting both children and adults over 25, and generated more cross-protective immunity between its variants.
That distinction is now mostly academic. No confirmed cases of the Yamagata lineage have been detected anywhere in the world since March 2020. The FDA has stated that Yamagata no longer poses a public health threat. As a result, the World Health Organization recommended that trivalent flu vaccines for the 2024-2025 season include only a Victoria lineage strain. Quadrivalent vaccines still contain a Yamagata component, but the global shift toward trivalent formulations reflects the reality that only one B lineage is still circulating.
Why Type B Hits Children Harder
While influenza A is responsible for the majority of pediatric flu deaths in most years, type B accounts for a meaningful share. During the 2024-2025 season, 280 children in the United States died from flu-related causes. Influenza B was associated with 38 of those deaths, about 14% of the total. In two previous seasons (2012-2013 and 2019-2020), type B actually caused more pediatric deaths than type A.
The complications that precede these deaths are severe. Among children with available clinical data, half experienced shock or sepsis before death. Pneumonia occurred in 38%, acute respiratory distress syndrome in 28%, seizures in 24%, and brain inflammation in 18%. These numbers reflect both flu types combined, but they illustrate why any flu infection in a young child deserves attention, regardless of type.
How It Spreads and How Long You’re Contagious
Influenza B follows the same transmission pattern as type A. After exposure, symptoms typically appear within one to four days. You become contagious about a day before symptoms start and remain infectious for roughly five to seven days after that. Children, people with weakened immune systems, and those who are severely ill can shed the virus for 10 days or more, which is one reason flu spreads so efficiently through schools and daycare settings.
What Recovery Looks Like
A typical bout of flu, whether type A or B, follows a fairly predictable arc. The first three days bring the worst of it: sudden fever, headache, muscle pain, weakness, dry cough, and sore throat. By day four, fever and body aches usually begin to ease, but the cough and sore throat become more noticeable, and fatigue can feel overwhelming. Around day eight, most symptoms are fading, though the cough and tiredness often linger for one to two weeks or longer. That lingering fatigue catches many people off guard, especially with type B, which can feel deceptively mild at the start.
Testing for Type B
Most people who visit a doctor with flu symptoms will get a rapid influenza diagnostic test, the kind that returns results in about 15 minutes. These tests can distinguish between type A and type B, but they’re less sensitive for B. The FDA requires rapid tests to detect influenza B with at least 80% sensitivity, meaning roughly one in five type B infections could be missed. Specificity is better at 95%, so a positive result for type B is reliable.
For hospitalized patients or cases where a rapid test comes back negative despite strong clinical suspicion, molecular tests like RT-PCR offer much higher accuracy. These are the gold standard for confirming which type and subtype of flu is involved.
Treatment Options
The same antiviral medications used for influenza A also work against type B. The most commonly prescribed option blocks a viral enzyme that the virus needs to spread from cell to cell within your body. It works best when started within 48 hours of symptom onset and typically shortens illness by a day or so.
A newer antiviral that works through a different mechanism has shown particular promise against type B. In a randomized trial, it reduced the time to symptom improvement by more than 24 hours compared to the older standard treatment in adolescents and adults with influenza B infections. This makes it a noteworthy option when type B is confirmed, though both medications are effective.
For most healthy adults and older children, flu type B resolves on its own with rest, fluids, and fever management. Antivirals are most important for people at higher risk of complications: young children, older adults, pregnant women, and those with chronic health conditions like asthma, diabetes, or heart disease.
Vaccination and Type B
Seasonal flu vaccines are updated every year to match circulating strains. For the 2024-2025 northern hemisphere season, the WHO recommended including a Victoria lineage strain as the type B component. Since Yamagata appears to have disappeared from circulation, the practical effect is that current vaccines target the only B lineage you’re likely to encounter.
Flu vaccines are less effective against type B in some years than others, partly because the Victoria lineage mutates relatively quickly. Still, vaccination remains the most effective way to reduce the severity of illness and prevent the serious complications that make influenza B dangerous for vulnerable groups.